fda glp-1 warning 2025 november Scam warning: shoppers warned as thousands of social media pages target weight loss drug buyers FDA Sends Warning Letters to

If the manufacturer did not adequately communicate risks to healthcare providers, doctors could not pass that information along to patients

This is a mechanism-level description of a research compound, not a statement of proven clinical benefit in humans

Cardiovascular and renal outcomes with Efpeglenatide in type 2 diabetes

The pharma industry giant has seen explosive sales growth for its GLP-1 agonist drug, semaglutide

Insurance Telehealth GLP-1 programs are mostly cash-pay with varying insurance options

Clinical and preclinical research demonstrates that maintaining optimal GSH levels supports liver function, immune cell activity, mitochondrial protection, and overall cellular homeostasis [3] [9]